Redicine Medsol

Ahmedabad, India Founded: 2020 • Age: 6 yrs
Medical adherence devices are supplied for cardiac and cancer patients.
Annual revenue $19,701 Latest available
Total funding $97,248 1 rounds
Employees 1 Tracked headcount
Investors 7 Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Redicine Medsol

Redicine Medsol is a company based in Ahmedabad (India) founded in 2020 by Dhaumil Parmar, Kush Prajapati, Harsh Mangukiya, and Raj Urvish Shah. Redicine Medsol has raised $97.25 thousand across 1 funding round from investors including Ducon Consultants, Las Olas and Unitve Ventures. The company has 1 employees as of February 26, 2025. Redicine Medsol offers products and services including ReMed+ and Redicine App. Redicine Medsol operates in a competitive market with competitors including MedMinder Systems, AdhereTech, Omcare, Berkshire Biomedical and KEEP, among others.

  • Headquarter Ahmedabad, India
  • Employees 1 as on 26 Feb, 2025
  • Founders Dhaumil Parmar, Kush Prajapati, Harsh Mangukiya, Raj Urvish Shah
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Redicine Medsol Private Limited
  • Date of Incorporation 29 Jun, 2020
  • Jurisdiction Ahmedabad, Gujarat, India
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $19.7 K (USD)
    -20.23
    as on Mar 31, 2024
  • Net Profit
    -$31.98 K (USD)
    16.56
    as on Mar 31, 2024
  • EBITDA
    -$30.24 K (USD)
    49.18
    as on Mar 31, 2024
  • Total Equity Funding
    $97.25 K (USD)

    in 1 rounds

  • Latest Funding Round
    $97.25 K (USD), Seed

    Oct 13, 2022

  • Investors
  • Employee Count
    1

    as on Feb 26, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Redicine Medsol

Redicine Medsol offers a comprehensive portfolio of products and services, including ReMed+ and Redicine App.

Product name locked
Category locked
Primary

Device for organizing medications with reminders to prevent errors.

Product name locked
Category locked
Locked

App for sending smart reminders and tracking adherence to medications.

Funding Insights of Redicine Medsol

Redicine Medsol has successfully raised a total of $97.25K through 1 strategic funding round. The most recent funding activity was a Seed round of $97.25 thousand completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Redicine Medsol

Redicine Medsol has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Ducon Consultants, Las Olas and Unitve Ventures.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Early-stage investments in US tech and life sciences are targeted.
Locked Locked Locked
Provider of diversified management consulting services
Locked Locked Locked
Structural and industrial design services with expertise in buildings and manufacturing projects.
Locked Locked Locked
Premium access

Investor details for Redicine Medsol

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Redicine Medsol

Investments
Premium access

Investment portfolio details for Redicine Medsol

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Redicine Medsol

Premium access

Detailed financials for Redicine Medsol

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Redicine Medsol Comparisons

Redicine Medsol Primary company
Description
Medical adherence devices are supplied for cardiac and cance...
Location
Ahmedabad, India
Founded Year
2020
Annual Revenue
$19.7 K (USD)
Net Profit
-$31.98 K (USD)
EBITDA
-$30.24 K (USD)
Employees
1
As of 2025
Premium access

Peer comparison for Redicine Medsol

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Redicine Medsol

Redicine Medsol operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedMinder Systems, AdhereTech, Omcare, Berkshire Biomedical and KEEP, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Medication adherence is monitored via smart pillbox organizers.
Locked Locked Locked
Smart pill bottles that improve medication adherence
Locked Locked Locked
Remote monitoring and medication adherence solutions for healthcare professionals
Locked Locked Locked
Cloud-based smart devices for drug dispensing are provided.
Locked Locked Locked
Smart medicine storage devices with app-based alerts are provided.
Locked Locked Locked
Provider of online medication adherence management platform for patients and healthcare facilities
Premium access

Detailed competitors of Redicine Medsol

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Redicine Medsol

Premium access

Complete news archive for Redicine Medsol

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Redicine Medsol

Redicine Medsol was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Redicine Medsol is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Kush Prajapati is the current CEO of Redicine Medsol. They have also founded this company.

Redicine Medsol is a funded company, having raised a total of $97.25K across 1 funding round to date.

As of Feb 26, 2025, the latest employee count at Redicine Medsol is 1.

Annual revenue of Redicine Medsol is $19.7K as on Mar 31, 2024.

Redicine Medsol was founded in 2020 and is based in Ahmedabad, India. Operations focus on the health technology sector, where medical adherence devices are developed for patients with cardiac and cancer conditions. Smart pill boxes are offered to organize and store medications, deliver reminders through connected mobile devices, and produce detailed reports on consumption patterns. Services target improved medication management in clinical settings.

Redicine Medsol's top competitors include MedMinder Systems, AdhereTech and Berkshire Biomedical.

Redicine Medsol offers ReMed+ and Redicine App.

Redicine Medsol has 7 investors. Key investors include Ducon Consultants, Las Olas, Unitve Ventures, Shital Bhavik Patel, and Tarang Pallav Chokhani.

The valuation of Redicine Medsol is $1.07M as of Oct 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available